Arenavirus nucleoproteins prevent activation of nuclear factor kappa B. - Wikidata - wikimedia - TriplyDB

Arenavirus nucleoproteins prevent activation of nuclear factor kappa B.

Arenavirus nucleoproteins prevent activation of nuclear factor kappa B.

http://www.wikidata.org/entity/Q40285838

about

Reporter-Expressing, Replicating-Competent Recombinant Arenaviruses Junín virus pathogenesis and virus replication Pathogenic mechanisms involved in the hematological alterations of arenavirus-induced hemorrhagic fevers Structure of the LCMV nucleoprotein provides a template for understanding arenavirus replication and immunosuppression Endothelial cell dysfunction in viral hemorrhage and edema.Comparative analysis of disease pathogenesis and molecular mechanisms of New World and Old World arenavirus infections.The human cytomegalovirus UL26 protein antagonizes NF-κB activation.A systems biology starter kit for arenaviruses.Early virus-host interactions dictate the course of a persistent infection Development of live-attenuated arenavirus vaccines based on codon deoptimization Highly Pathogenic New World and Old World Human Arenaviruses Induce Distinct Interferon Responses in Human Cells.Lymphocytic Choriomeningitis Virus Differentially Affects the Virus-Induced Type I Interferon Response and Mitochondrial Apoptosis Mediated by RIG-I/MAVS.D471G mutation in LCMV-NP affects its ability to self-associate and results in a dominant negative effect in viral RNA synthesis Vascular leak ensues a vigorous proinflammatory cytokine response to Tacaribe arenavirus infection in AG129 mice Innate immune response to arenaviral infection: a focus on the highly pathogenic New World hemorrhagic arenaviruses.Activation of the RLR/MAVS Signaling Pathway by the L Protein of Mopeia Virus.Production of CXC and CC chemokines by human antigen-presenting cells in response to Lassa virus or closely related immunogenic viruses, and in cynomolgus monkeys with lassa fever.Reverse Genetics Approaches to Control Arenavirus.Development of live-attenuated arenavirus vaccines based on codon deoptimization of the viral glycoprotein.Host cell factors as antiviral targets in arenavirus infection.Immune responses and Lassa virus infection.Targeting virulence mechanisms for the prevention and therapy of arenaviral hemorrhagic fever.Human hemorrhagic Fever causing arenaviruses: molecular mechanisms contributing to virus virulence and disease pathogenesis.A Map of the Arenavirus Nucleoprotein-Host Protein Interactome Reveals that Junín Virus Selectively Impairs the Antiviral Activity of Double-Stranded RNA-Activated Protein Kinase (PKR).Residues K465 and G467 within the Cytoplasmic Domain of GP2 Play a Critical Role in the Persistence of Lymphocytic Choriomeningitis Virus in Mice.Inhibition of arenavirus by A3, a pyrimidine biosynthesis inhibitor.Differential Immune Responses to New World and Old World Mammalian Arenaviruses.Arenavirus nucleoprotein targets interferon regulatory factor-activating kinase IKKε.Lassa Virus Reverse Genetics.Resistance of human plasmacytoid dendritic CAL-1 cells to infection with lymphocytic choriomeningitis virus (LCMV) is caused by restricted virus cell entry, which is overcome by contact of CAL-1 cells with LCMV-infected cells.Evolutionary analysis of Old World arenaviruses reveals a major adaptive contribution of the viral polymerase.Arenavirus Genome Rearrangement for the Development of Live Attenuated Vaccines.Exonuclease domain of the Lassa virus nucleoprotein is critical to avoid RIG-I signaling and to inhibit the innate immune response.The exonuclease domain of Lassa virus nucleoprotein is involved in antigen-presenting-cell-mediated NK cell responses.Development of Recombinant Arenavirus-Based Vaccines.Interactome analysis of the lymphocytic choriomeningitis virus nucleoprotein in infected cells reveals ATPase Na+/K+ transporting subunit Alpha 1 and prohibitin as host-cell factors involved in the life cycle of mammarenaviruses.BST-2 controls T cell proliferation and exhaustion by shaping the early distribution of a persistent viral infection DDX3 suppresses type I interferons and favors viral replication during Arenavirus infection Current research for a vaccine against Lassa hemorrhagic fever virus The S Genome Segment Is Sufficient to Maintain Pathogenicity in Intra-Clade Lassa Virus Reassortants in a Guinea Pig Model

P2860

Q26742028-99651C08-BA11-4A84-9143-2991F897C10A Q26992011-6B3555C7-A7C1-4A5C-B420-AC1A597BF9EA Q27024900-F06D1843-81A5-4D41-BE24-020E106D68B1 Q27684274-807587DE-A355-4A39-8B10-C52A956830E2 Q33419868-6F4B8ACE-88B1-4236-A947-5DAFA59507EB Q33887328-21D7753A-E865-4497-84B6-773F3523D49B Q34594875-7C0FFF45-09C4-4B48-BCAB-5AA246CADEAE Q34647510-BFBBFCDF-264A-4E4C-A097-F2C50D97188B Q34876341-648736E2-033A-44A3-8072-69B8FE8A2D09 Q35487706-CBAABAD4-E9E0-4429-A09C-6CE31C0FC56B Q35758637-0B7AF27E-857C-4A79-A000-471BEB9B338E Q35760477-2A4003B9-DEEF-4DD4-9724-CEDC4A9AD43E Q36395857-C8233D3E-22E0-48A7-B9D8-11132DD388FC Q37000842-7C783589-A39E-490E-8D55-891AD57DEAF5 Q37394607-B769A6C1-A156-4EF7-A39B-68929D6F1C9D Q37409248-BEA26AFB-BF11-471C-854D-9FF948116A87 Q37464889-5A076FBA-EF81-4722-9504-0FCE7EE35995 Q37543755-C39E54A4-D588-4DAB-BF06-2C88C7185AA3 Q37546745-DDE67D13-37F8-4A17-9F93-AE97D2EC3E42 Q38061425-34FA8EE4-EF51-41CE-8569-69452E8F8A4C Q38064284-D689ADFC-858F-44EF-ADB8-A889D686A55F Q38069359-240B0F0B-8883-4F76-9548-6D918B9FA643 Q38502997-D9CC5004-BB70-43B7-A64D-9BCC09CCA8C6 Q38702369-95512EBE-81F8-4F41-93DD-CA9A302B8B73 Q38736159-5E9AF51B-A910-4774-A8F1-3D81213FA6CA Q39066377-775848CC-B113-4638-8BCF-D059B1F81507 Q39302482-88BE56DF-6F8E-4117-B064-9739B8E6A376 Q39358991-F7811F02-2F0C-4835-B00C-492154DFAC88 Q40056797-6C432A56-5488-4ABE-84CD-48B51DC70733 Q40069302-EF0180F6-9304-4E01-A4E9-C14F827BECAE Q40093891-7784F0DD-6085-40F0-9F8E-5ED9B877DB37 Q40156113-D7A4E23C-C827-46E5-9AD0-349888E75B0A Q40189585-3D668713-8C02-4F3B-A680-ED68605AE163 Q40189592-6E97531D-C823-47B9-A8CB-434380FFD1B1 Q40259618-E83088C4-C55D-44A9-9F97-C23442228699 Q50238755-8C108DBF-1B4B-4467-9419-6A14EA5959D3 Q56895711-84550F1F-91B1-41A9-A33B-0F1A5B02D4A4 Q56898872-74E30C90-4CBC-44A8-A65A-7A2742D628CA Q56909960-BDD588A4-4169-48B2-91CA-5848FEFA7A4D Q56913187-6BC3F291-7DB8-4ACD-83E8-8D99109D44B1

P2860

Arenavirus nucleoproteins prevent activation of nuclear factor kappa B.

http://www.wikidata.org/entity/Q40285838

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Arenavirus nucleoproteins prevent activation of nuclear factor kappa B.

@en

type

label

Arenavirus nucleoproteins prevent activation of nuclear factor kappa B.

@en

prefLabel

Arenavirus nucleoproteins prevent activation of nuclear factor kappa B.

@en

P1433

Q40285838-EA1B3768-FEE6-4C25-B869-C508686E9210

P1476

Q40285838-9DC4F813-BE9C-4B99-9C5C-B0CFD333E17B

P2093

Q40285838-22C05E14-5E1A-4BFE-9EDD-DF8DDE983C6D

Q40285838-3DA836C3-AD4B-4CA8-8468-CD1F6F637F79

Q40285838-7F42A0B6-5479-4999-87E9-4E8515E365B3

Q40285838-E5BE1FE1-7A55-44F5-8D15-9DED273B3B64

P2860

Q40285838-0229A2B9-86CA-479C-9C1B-F94A8990DB01

Q40285838-02A0060F-2B88-45A6-92FA-738D2399F3FF

Q40285838-05F23358-E82B-4FFD-B39F-6D6D9856359A

Q40285838-0968D487-364A-4E72-B1C7-1F98B911858C

Q40285838-0AE1E1A5-CEAF-48E5-ACA3-DDA82F4D99D7

Q40285838-0E19261F-F347-4025-8B81-48462BCBAA16

Q40285838-12B63371-D355-43CF-9231-4CB849E89C6A

Q40285838-1319DCA4-FD67-48A1-BD25-096DEED17A3C

Q40285838-2152CEB6-13F3-4B18-8894-FE89F3EF5D12

Q40285838-22A0629F-0E93-49CC-BBA0-57A61BA9D3C7

P304

Q40285838-DD80B6EA-BB2A-490D-AC89-EED75F6BA8D3

P31

Q40285838-430FF789-DB36-429A-91D3-25B00519811C

P356

Q40285838-3199CF4A-8091-4EAD-A0E6-222E0B6324A8

P407

Q40285838-5C54CCE3-2F5F-458C-821E-366D3E5526C3

P433

Q40285838-FE9D44A0-A901-4734-9F36-F706C687537D

P478

Q40285838-351C99C4-EB1D-4C0A-AD40-BC5549217BAA

P50

Q40285838-A384E16C-B655-44C8-B4B7-6512F5BD2C04

Q40285838-C42B1F07-5800-4DAE-8944-ADF1C47E4264

P577

Q40285838-3DD93F21-62CF-4D35-8831-4BBB99B23072

P5875

Q40285838-FC63DA2A-4061-48F9-8C6F-0A394729B3B8

P698

Q40285838-0E47DCED-2336-44E9-9E6C-A1F25DEB5010

P932

Q40285838-6CDA9803-49D1-4CA0-8051-AE4A414D4C49

P356

P1433

Journal of Virology

P1476

Arenavirus nucleoproteins prevent activation of nuclear factor kappa B

@en

P2093

Christelle Pythoud

http://www.w3.org/2001/XMLSchema#string

Emilio Ortiz-Riaño

http://www.w3.org/2001/XMLSchema#string

Juan C de la Torre

http://www.w3.org/2001/XMLSchema#string

W W Shanaka I Rodrigo

http://www.w3.org/2001/XMLSchema#string

P2860

Z proteins of New World arenaviruses bind RIG-I and interfere with type I interferon induction

IKK-i, a novel lipopolysaccharide-inducible kinase that is related to IkappaB kinases

NF-kappaB activation by a signaling complex containing TRAF2, TANK and TBK1, a novel IKK-related kinase

IKKepsilon is part of a novel PMA-inducible IkappaB kinase complex

Type I interferon [corrected] gene induction by the interferon regulatory factor family of transcription factors

IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction

Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus

The measles virus V protein binds to p65 (RelA) to suppress NF-kappaB activity

Dissociation of a MAVS/IPS-1/VISA/Cardif-IKKepsilon molecular complex from the mitochondrial outer membrane by hepatitis C virus NS3-4A proteolytic cleavage

Deficiency of T2K leads to apoptotic liver degeneration and impaired NF-kappaB-dependent gene transcription

P304

8185-8197

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/JVI.07240-11

http://www.w3.org/2001/XMLSchema#string

P407

P433

15

http://www.w3.org/2001/XMLSchema#string

P478

86

http://www.w3.org/2001/XMLSchema#string

P50

Luis Martinez-Sobrido

P577

2012-05-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

225059441

http://www.w3.org/2001/XMLSchema#string

P698

22623788

http://www.w3.org/2001/XMLSchema#string

P932

3421694

http://www.w3.org/2001/XMLSchema#string